Dhingra Kapil is listed as a director on 5 SEC Form D filings by 1 issuer between Aug 2012 and Mar 2014: Exosome Diagnostics, Inc. (Waltham, MA — biotechnology — 2012–2014; $30.3M reported sold to 43 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Geert-Jan Mulder (5 shared filings), James McCullough (5 shared filings), Joseph Boystak (5 shared filings), Peter Johann (5 shared filings), Sara Barrington (5 shared filings) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Dhingra. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 6 court cases matching the name, 3 bankruptcy cases matching the name listed in Key records below.
What this means 9 records came back, including 2 court cases still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 5 public filings for Dhingra Kapil and found 10 differences, 3 worth asking the sponsor about: Bankruptcy case: Kapil Kumar Jain and Malika Jain; Bankruptcy case: Kapil Sharma; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.